Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (821-830 of 850) with videos related to

Pageof 85
Sort By:
World Journal of Urology|May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancerQuynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery|May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancersFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Cancer Medicine|January 2, 2020
Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patientsFranziska Büscheck, Mariam Sulimankhil, Nathaniel Melling, et al.
The Journal of Urology|January 10, 2004
Is year of radical prostatectomy a predictor of outcome in prostate cancer?Ilias Cagiannos, Pierre Karakiewicz, Markus Graefen, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
European Urology|April 10, 2025
Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working GroupMarcio Covas Moschovas, Shady Saikali, Marco Sandri, et al.
The Journal of Urology|February 19, 2020
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node DissectionsNicola Fossati, Simone Scarcella, Giorgio Gandaglia, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Pageof 85

Showing results (821-830 of 850) with videos related to

Sort By:
Pageof 85
World Journal of Urology|May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancerQuynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery|May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancersFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Cancer Medicine|January 2, 2020
Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patientsFranziska Büscheck, Mariam Sulimankhil, Nathaniel Melling, et al.
The Journal of Urology|January 10, 2004
Is year of radical prostatectomy a predictor of outcome in prostate cancer?Ilias Cagiannos, Pierre Karakiewicz, Markus Graefen, et al.
European Urology|August 3, 2012
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assayJens Hansen, Marco Auprich, Sascha A Ahyai, et al.
European Urology Focus|July 30, 2017
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk AnalysisLorenzo Tosco, Annouschka Laenen, Alberto Briganti, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
European Urology|April 10, 2025
Outcomes of Salvage Robotic-assisted Radical Prostatectomy: High-volume Multicentric Data from the European Association of Urology Robotic Urology Section Scientific Working GroupMarcio Covas Moschovas, Shady Saikali, Marco Sandri, et al.
The Journal of Urology|February 19, 2020
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of <sup>68</sup>Ga-PSMA and <sup>11</sup>C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node DissectionsNicola Fossati, Simone Scarcella, Giorgio Gandaglia, et al.
Oncology Letters|October 16, 2019
Upregulation of SPDEF is associated with poor prognosis in prostate cancerJan Meiners, Katharina Schulz, Katharina Möller, et al.
Pageof 85